OncoSec Medical Inc. To Present At 2nd Annual Sachs Cancer Bio Partnering & Investment Forum
3/17/2014 8:27:21 AM
OncoSec Medical Inc. (OTCQB: ONCS), a company developing its advanced-stage ImmunoPulse DNA-based immunotherapy to treat solid tumors, today announced that Punit Dhillon, President and CEO, will present a corporate overview of the company at the 2nd Annual Sachs Cancer Bio Partnering & Investment Forum at the New York Academy of Sciences on Wednesday, March 19th at 3:00 p.m. (EST).
Help employers find you! Check out all the jobs and post your resume.
comments powered by